Diabetes treatment is constantly advancing, with new therapeutic options developing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://victorqgqc055262.oblogation.com/37956849/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment